Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
226
DELISTED
Immunogen Inc
IMGN
| $57.1M | 0.11% |
3,968,772
+3,029,108
| +322% | +$33.3M |
|
|
ANAC
227
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $57.1M | 0.11% |
736,962
-312,827
| -30% | -$20.5M |
|
228
Allison Transmission
ALSN
$11B
| $57M | 0.11% |
1,946,506
-1,957,336
| -50% | -$60.8M |
|
|
CTXS
229
DELISTED
Citrix Systems Inc
CTXS
| $56.9M | 0.11% |
1,018,105
+789,193
| +345% | +$41.9M |
|
|
PNRA
230
DELISTED
Panera Bread Co
PNRA
| $56.4M | 0.11% |
322,824
+232,929
| +259% | +$41.9M |
|
231
Align Technology
ALGN
$11.5B
| $56.4M | 0.11% |
899,468
+790,886
| +728% | +$46.7M |
|
232
SL Green Realty
SLG
$4.07B
| $56.4M | 0.11% |
529,866
+63,838
| +14% | +$7.49M |
|
233
Verisk Analytics
VRSK
$24.4B
| $56.3M | 0.11% |
774,082
+759,451
| +5,191% | +$55.8M |
|
234
TE Connectivity
TEL
$58.9B
| $56.1M | 0.11% |
872,268
+297,522
| +52% | +$20.6M |
|
|
VISN
235
Vistance Networks Inc
VISN
$2.59B
| $55.5M | 0.11% |
1,820,402
-48,165
| -3% | -$1.46M |
|
|
MBLY
236
DELISTED
Mobileye N.V.
MBLY
| $55.4M | 0.1% |
1,042,444
+555,550
| +114% | +$26.3M |
|
237
Neurocrine Biosciences
NBIX
$15.5B
| $55.3M | 0.1% |
1,156,887
-315,986
| -21% | -$13.4M |
|
|
CIM
238
Chimera Investment
CIM
$964M
| $54.9M | 0.1% |
1,333,965
+440,450
| +49% | +$19.7M |
|
239
iShares Biotechnology ETF
IBB
$10.7B
| $54.6M | 0.1% |
+443,622
| New | +$53.1M |
|
|
JNPR
240
DELISTED
Juniper Networks
JNPR
| $54.3M | 0.1% |
2,090,870
+1,951,502
| +1,400% | +$51.2M |
|
|
BRCM
241
DELISTED
BROADCOM CORP CL-A
BRCM
| $54.2M | 0.1% |
1,052,227
-1,884,502
| -64% | -$91.7M |
|
|
XLNX
242
DELISTED
Xilinx Inc
XLNX
| $54M | 0.1% |
1,221,866
+855,429
| +233% | +$38.5M |
|
243
CALL
Energy Transfer Partners
ET
$73B
| $53.8M | 0.1% |
1,676,600
-768,600
| -31% | -$25.7M |
|
|
AXLL
244
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $53.7M | 0.1% |
1,489,601
-1,525,933
| -51% | -$60.9M |
|
245
Reliance Steel & Aluminium
RS
$19.8B
| $53.2M | 0.1% |
879,321
+193,915
| +28% | +$12.3M |
|
|
HPP
246
Hudson Pacific Properties
HPP
$787M
| $53.1M | 0.1% |
267,432
+112,051
| +72% | +$24.1M |
|
|
ZLTQ
247
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $52.1M | 0.1% |
1,769,356
+207,916
| +13% | +$6.28M |
|
248
Xylem
XYL
$26.5B
| $51.9M | 0.1% |
1,399,583
+642,747
| +85% | +$23.4M |
|
249
Acadia Healthcare
ACHC
$2.59B
| $51.8M | 0.1% |
+661,409
| New | +$47.6M |
|
|
RHT
250
DELISTED
Red Hat Inc
RHT
| $51.8M | 0.1% |
681,900
+573,900
| +531% | +$44.1M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.